Elisabeth M Terveer (E M Terveer)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Klebsiella Pneumoniae

Coronavirus Disease

Top Venues

Nature communications

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Josbert J Keller, Elisabeth M Terveer
Editorial: Continuous monitoring to improve outcome of treatment-the next step towards safe and effective faecal microbiota transplantation. Alimentary pharmacology & therapeutics 58 (9) (2023)
Bas Groenewegen, Emilie van Lingen, Rogier E Ooijevaar, Els Wessels, Mariet C W Feltkamp, Eline Boeije-Koppenol, Hein W Verspaget, Ed J Kuijper, Joffrey van Prehn, Josbert J Keller, Elisabeth M Terveer, null null
How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation. PloS one 17 (3) (2022)
R E Ooijevaar, E van Nood, A Goorhuis, Elisabeth M Terveer, Joffrey van Prehn, H W Verspaget, Y H van Beurden, Marcel G W Dijkgraaf, J J Keller
Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature. Microorganisms 9 (3) (2021)
Ilse M Boekhoud, Bastian V H Hornung, Eloísa Sevilla, Céline Harmanus, Ingrid M J G Bos-Sanders, Elisabeth M Terveer, Rosa Bolea, Jeroen Corver, Ed J Kuijper, Wiep Klaas Smits
Plasmid-mediated metronidazole resistance in Clostridioides difficile. Nature communications 11 (1) (2020)
Elisabeth M Terveer, Roel H T Nijhuis, Monique J T Crobach, Cornelis W Knetsch, Karin E Veldkamp, Jairo Gooskens, Ed J Kuijper, Eric C J Claas
Prevalence of colistin resistance gene (mcr-1) containing Enterobacteriaceae in feces of patients attending a tertiary care hospital and detection of a mcr-1 containing, colistin susceptible E. coli. PloS one 12 (6) (2017)